About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Losartan Therapy in Pulmonary Hypertension

NCT00519870·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Baskent University

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Pulmonary hypertension diagnosed by Doppler echocardiographic examination (a mean pulmonary artery pressure of \> 26mmHg)

You may not be if

acute infectious or inflammatory disease,
exacerbation of chronic obstructive pulmonary disease,
malignancy,
acute coronary syndrome in the last 4 weeks,
uncontrolled arrhythmia and hypertension,
decompensated heart failure,
acute pulmonary emboli,
thrombus in a lower extremity,
oxygen saturation below 85% at rest,
failure to cooperate with CPET

The record

StatusCompleted

PhasePhase 3

Taking part—

StartedJan 2005

UpdatedAug 23, 2007

Conditions

Pulmonary Hypertension

Clareo Health | Losartan Therapy in Pulmonary Hypertension